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Hippocampal neurogenesis is important for certain
forms of cognition, and failing neurogenesis has
been implicated in neuropsychiatric diseases. The
neurogenic capacity of hippocampal neural stem/
progenitor cells (NSPCs) depends on a balance
between quiescent and proliferative states. Here,
we show that the rate of fatty acid oxidation (FAO)
regulates the activity of NSPCs. Quiescent NSPCs
show high levels of carnitine palmitoyltransferase
1a (Cpt1a)-dependent FAO, which is downregulated
in proliferating NSPCs. Pharmacological inhibition
and conditional deletion of Cpt1a in vitro and in vivo
leads to altered NSPC behavior, showing that Cpt1a-
dependent FAO is required for stem cell maintenance
and proper neurogenesis. Strikingly, manipulation of
malonyl-CoA, the metabolite that regulates levels of
FAO, is sufficient to induce exit from quiescence
and to enhance NSPC proliferation. Thus, the data
presented here identify a shift in FAO metabolism
that governs NSPC behavior and suggest an instruc-
tive role for fatty acid metabolism in regulating NSPC
activity.
INTRODUCTION
New neurons are generated throughout life in the mammalian
hippocampus (Spalding et al., 2013; van Praag et al., 2002).
This process, called adult neurogenesis, is critically involved
in a variety of hippocampus-dependent forms of learning and
memory (Clelland et al., 2009; Deng et al., 2010; Dupret
et al., 2008; Gonc¸alves et al., 2016; Nakashiba et al., 2012;
Sahay et al., 2011a, 2011b). In addition, failing or altered neuro-
genesis has been associated with a number of neuropsychi-
atric diseases, such as major depression, epilepsy, and cogni-
tive aging, suggesting adult hippocampal neurogenesis is
relevant for human health and disease (Christian et al., 2014;2144 Cell Reports 20, 2144–2155, August 29, 2017 ª 2017 The Autho
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stem/progenitor cells (NSPCs) in the adult hippocampus reside
in the subgranular zone (SGZ) of the dentate gyrus (DG), where
they proliferate and generate new glutamatergic, excitatory
granule cells that become integrated into pre-existing cir-
cuitries over the course of several weeks (Espo´sito et al.,
2005; Ge et al., 2007; Lagace et al., 2007; Seri et al., 2001;
Toni et al., 2008; Zhao et al., 2006). Previous reports have sug-
gested a delicate balance between quiescent, radial glia-like
NSPCs and more proliferative NSPCs controlled by key
signaling pathways, such as Notch and BMP signaling, resem-
bling molecular mechanisms identified in the developing brain
(Ables et al., 2010; Ehm et al., 2010; Lugert et al., 2010; Ming
and Song, 2011; Mira et al., 2010). In addition, accumulating
evidence in NSPCs and other somatic stem cells, such as
hematopoietic stem cells (HSCs), has suggested that cellular
metabolism might govern the levels of activity of adult stem
cells in vivo and during cellular reprogramming in vitro (Chorna
et al., 2013; David, 2011; Folmes et al., 2011; Homem et al.,
2015; Ito et al., 2012; Ito and Suda, 2014; Knobloch et al.,
2013; Ryall et al., 2015). However, whether specific metabolic
programs regulate the balance between NSPC quiescence
and proliferation remains unknown. The brain is the organ
with the highest glucose consumption rate (Mergenthaler
et al., 2013), and neurons are mainly dependent on glucose
and lactate for normal function. The role of lipids in brain meta-
bolism has been much less studied, given the predominance of
glucose consumption. Furthermore, the relatively small propor-
tion of NSPCs compared to the cellular mass of the brain might
have led to the overlooking of other metabolic pathways
relevant for NSPCs. Indeed, we have previously identified an
important role for lipid metabolism in NSPCs, showing that
the build-up of lipids through de novo lipogenesis is crucial
for proliferation (Knobloch et al., 2013). However, whether the
metabolic counterpart, the breakdown of lipids called fatty
acid oxidation (FAO), is important to regulate NSPC behavior
remains poorly understood. We here characterized metabolic
adaptations from a quiescent to an activated NSPC state and




Quiescent NSPCs Have High Levels of FAO
To studymetabolic adaptations during NSPC quiescence versus
activation, we modified previously established in vitro protocols
that are based on the induction of NSPC quiescence by bone
morphogenic protein 4 (BMP4), leading to cellular quiescence
over the course of three days (Figure 1A) (Martynoga et al.,
2013; Mira et al., 2010). BMP4-induced quiescence was revers-
ible with restored proliferation and differentiation potential after
removal of quiescence cues, suggesting a reliable in vitro model
of functional NSPC quiescence (Figures S1A–S1C). We first
analyzed thewhole proteome of proliferating compared to quies-
cent NSPCs and found proteins associated with FAO (the break-
down of fatty acids into acetyl-coenzyme A [CoA] in the
mitochondria) to be highly enriched in quiescent NSPCs (Figures
1B and S1D–S1F; Tables S1 and S2). To test whether the high
expression levels of proteins associated with FAO translate
into functionally elevated levels of FAO, we used radioactive
FAO measurements. A labeled fatty acid (3H-palmitic acid) was
added to the medium. During oxidation of such labeled palmitic
acid into eight acetyl-CoAs, measurable radioactive labeled
water (3H2O) is produced, which serves as a readout of the
rate of FAO. Strikingly, we found high levels of FAO in quiescent
NSPCs that were substantially lower in proliferating NSPCs
(Figure 1C).
To characterize FAO in quiescent NSPCs, we analyzed the
expression of carnitine palmitoyltransferase 1a (Cpt1a), a rate-
limiting mitochondrial enzyme of FAO that mediates the trans-
port of fatty acids into the mitochondria (Houten and Wanders,
2010). Corroborating the proteomics data, we found strong
upregulation of Cpt1a using qRT-PCR and western blot ana-
lyses, showing a substantial increase in the expression of
Cpt1a in quiescent compared to proliferating NSPCs (Figures
1D and 1E). In line with the radioactive FAO measurements,
the increase in Cpt1a expression in quiescent NSPCs was
reversible (Figure 1D). Cpt1a co-labeled with the mitochondrial
dye Mitotracker in both quiescent and proliferating NSPCs (Fig-
ures 1H and S1H). In addition, Cpt1a was highly expressed in
NSPCs compared to their neuronal progeny when directly
isolated from the adult DG (3.5-fold upregulated in SOX2+ cells
versus DCX+ cells), as described previously (Bracko et al.,
2012; Shin et al., 2015). Collectively, these data indicate that
compared to proliferating NSPCs that are highly lipogenic (Kno-
bloch et al., 2013), quiescent NSPCs strongly express Cpt1a and
show high levels of functional FAO.
Next, we aimed to understand the molecular mechanism
underlying high levels of FAO in quiescent NSPCs. We have pre-
viously shown that Spot14 is selectively expressed in quiescent
NSPCs in vivo (Knobloch et al., 2013, 2014). When we induced
quiescence in vitro, we found a >30-fold upregulation of
Spot14 mRNA using qRT-PCR (Figure 1F). Given that Spot14
negatively regulates malonyl-CoA levels (Colbert et al., 2010;
Knobloch et al., 2013), we expected that high levels of Spot14
in quiescent NSPCs would lead to low levels of malonyl-CoA.
Indeed, quiescent NSPCs showed a substantial decrease in
malonyl-CoA, as measured with mass spectrometry (Figure 1G).
The levels of acetyl-CoA, which are not affected by Spot14, werecomparable between proliferating and quiescent NSPCs
(Figure S1G). Because malonyl-CoA is an endogenous inhibitor
of Cpt1a, its levels determine the rate of FAO (Folmes et al.,
2013; Houten and Wanders, 2010). Thus, high levels of Spot14
accompanied by low levels of malonyl-CoA in quiescent NSPCs
promote high FAO (see also summary scheme Figure 5E).
High Levels of FAO Are Required to Sustain Cellular
Quiescence
To test for the functional relevance of FAO activity, we blocked
FAO in quiescent NSPCs using the irreversible Cpt1 inhibitor
Etomoxir. NSPCs were induced to quiescence and then
exposed to various doses of Etomoxir. Cell survival was
assessed using time-lapse imaging. Strikingly, such complete
FAO inhibition in quiescent NSPCs led to massive cell death in
a dose-dependent manner (Figure 2A). This finding indicates
that FAO is critically involved in maintaining adult hippocampal
NSPCs in a quiescent state and that absence of this pathway
is detrimental. Complete blockage of FAO using Etomoxir also
affected NSPCs kept under proliferating conditions by reducing
their proliferation, as assessed by time-lapse imaging, flow
cytometry analysis, and 5-ethynyl-2’-deoxyuridine (EdU)-pulse
labeling (Figures S2A–S2C). These findings are in line with a
recent report showing that proliferating NSPCs in the SVZ can
oxidize fatty acids (Stoll et al., 2015). Given the detectable levels
of FAO in proliferating NSPCs, (although much lower than in
quiescent NSPCs; Figure 1C) and the effect of blocking FAO
on proliferation, these data suggest that FAO is still to a certain
extend relevant during proliferation. However, in contrast to
quiescent NSPCs, abolishing FAO in proliferating NSPCs only
mildly affected their cell survival (Figures S2A–S2C).
Given the importance of FAO for NSPC behavior in vitro, we
next investigated why quiescent NSPCs require FAO. We used
two complementary approaches to analyze the fate of oxidized
fatty acids in NSPCs. First, we used radioactively labeled
14C-palmitic acid to determine the complete oxidation of fatty
acids, allowing for energy production. In contrast to the 3H-pal-
mitic acid labeling, where radioactive labeled 3H2O is produced
during the entire oxidation cycles into acetyl-CoAs, radioactively
labeled 14C-palmitic acid yields measureable 14CO2 only if the
resulting acetyl-CoAs are further oxidized in the tricarboxylic
acid (TCA) cycle. We found significantly higher levels of 14CO2
in quiescent NSPCs compared to proliferating NSPCs, suggest-
ing that quiescent NSPCs might use fatty acids as a fuel source
(Figure 2B). To confirm that quiescent NSPCs use FAO for
energy production, we determined their energy charge, as a
readout for the amount of energy available in the form of adeno-
sine triphosphate (ATP). We found that the energy charge signif-
icantly dropped following Etomoxir treatment, indicating that
FAO is indeed contributing to the amount of ATP generated in
quiescent NSPCs (Figure 2C), with the massive drop using
200 mm Etomoxir probably indicating reduced cell viability.
Next, we used 13C-labeled palmitic acid to trace the incorpo-
ration of labeled carbon atoms in quiescent versus proliferative
NSPCs (Figure 2D). During complete oxidation of such labeled
palmitic acid, labeled carbon atoms are cleaved off and trans-
ferred to TCA intermediates and amino acids derived from TCA
intermediates. The amount of incorporation of labeled carbonsCell Reports 20, 2144–2155, August 29, 2017 2145
Figure 1. Quiescent NSPCs Have a High Rate of FAO
(A) Exposure of NSPCs to a BMP4-containing quiescencemedium for three days leads to amassive decrease in proliferation. Shown are representative images of
proliferating (prol) and quiescent (quie) NSPCs and quantification of the mitotic cell marker phospho histone 3 (pH3) (mean ± SEM).
(B) Mass spectrometric comparison of the proteome of proliferating and quiescent NSPCs reveals FAO to be enriched in quiescent NSPCs. The histogram shows
the normalized abundance of proteins belonging to the GO term ‘‘Fatty acid oxidation’’ (gray = expression change of log2 < j1j, red = expression change of
log2% 1, enriched in quiescent cells).
(C) Radioactive FAOmeasurements using 3H-labeled palmitic acid revealed a significant increase in the rate of FAO in quiescent NSPCs compared to proliferating
NSPCs. Remarkably, this increase was reversed in quiescent NSPCs that had been re-exposed to proliferation conditions (ex quie), suggesting FAO is spe-
cifically upregulated upon quiescence entry (mean ± SD).
(D) mRNA levels of the key FAO enzyme Cpt1a are highly and reversibly upregulated in quiescent (quie) NSPCs compared to proliferating (prol) and formerly
quiescent (ex quie) NSPCs (mean ± SEM).
(E) The increase in Cpt1a mRNA levels is also reflected on protein levels, as revealed by western blot analysis (mean ± SEM).
(F) mRNA levels of the previously described novel quiescence marker Spot14 are highly upregulated in quiescent (quie) NSPCs compared to proliferating (prol)
NSPCs. This upregulation is reversible, as formerly quiescent (ex quie) NSPCs greatly reduce Spot14 mRNA levels. This suggests that the BMP4-induced in vitro
quiescence system indeed reflects features of in vivo NSPC quiescence (mean ± SEM).
(G) The endogenous Cpt1a inhibitor malonyl-CoA is lowered in quiescent NSPCs compared to proliferating NSPCs, as measured by mass spectrometry analysis
(mean ± SEM).
(H) Co-stainings against Cpt1a and a mitochondrial marker (Mitotracker) reveals the mitochondrial localization of Cpt1a in quiescent NSPCs. Shown is a
representative confocal image of maximum projections of individual channels and a 3D reconstruction.
Scale bars represent 50 mm (A) and 20 mm (H). ***p < 0.001; **p < 0.01.
See also Figure S1.
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Figure 2. High Levels of FAO Are Required to Sustain Cellular Quiescence
(A)Time-lapseanalysisofquiescentNSPCsexposed tovariousdosesof the irreversibleCpt1 inhibitor Etomoxir (50, 100,and200mM).Shownarea schematicoutline
of the experimental setup, the quantification of the area covered by quiescent NSPCs over time, and representative images. Complete block of FAO by Etomoxir
during quiescence leads to a dramatic and dose-dependent decrease of area covered over time, caused by cell death upon FAO inhibition (mean ± SEM).
(B–E) Quiescent NSPCs use FAO for energy purposes and may use it as an alternative carbon source.
(B) Radioactive FAO measurements using 14C-labeled palmitic acid revealed a significant increase in 14CO2 in quiescent NSPCs compared to proliferating
NSPCs, suggesting that at least part of the fatty acids are fully oxidized and might be used for energy purposes (mean ± SD).
(C) Energy charge measurements in quiescent NSPCs show that FAO indeed contributes to the amount of ATP generated, as treatment with various doses of
Etomoxir (50, 100, and 200 mM) reduced the energy charge significantly (mean ± SEM).
(D) Scheme outlining the path of 13C-labeled palmitic acid upon FAO. The oxidation of fatty acids results in acetyl-CoA, which can be fed into the TCA. The
metabolites measured with mass spectrometry in a 13C-incorporation assay are shown in bold.
(E) Quiescent NSPCs show an increase in 13C-incorporation in TCA intermediates and amino acids derived from TCA intermediates compared to proliferating
NSPCs (mean ± SD). These 13C-incorporation assay results suggest that fatty acids might also serve as an alternative carbon source in quiescent NSPCs.
(F) High levels of FAO in quiescent NSPCs are at least partially regulated through the transcription factor PPARa. Treatment for 48 hr with 100 mM of the PPARa
agonist WY14643 in proliferating NSPCs significantly reduced proliferation compared to control NSPCs, but proliferation was still far higher than in quiescent
NSPCs, as assessed by EdU pulsing. Shown are representative images and the corresponding quantification of EdU-positive cells (mean ± SEM).
(G) WY14643 treatment led to an upregulation of PPARa and its target FAO genes in proliferating NSPCs compared to control NSPCs, however, to a far lesser
extent than in quiescent NSPCs. Shown are the mRNA expression levels (mean fold change ± range) of PPARa, Peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC1a), Cpt1a, medium-chain acyl-CoA dehydrogenase (Acadm), long-chain acyl-CoA dehydrogenase (Acadl), and very long-
chain acyl-CoA dehydrogenase (Acadvl).
Scale bar represents 50 mm (A) and 20 mm (F). ***p < 0.001; **p < 0.01.
See also Figure S2 and Table S3.can be measured using mass spectrometry. We found highly
significant increases in the incorporation of 13C into TCA inter-
mediates as well as into amino acids derived from TCA interme-
diates in quiescent NSPCs (Figure 2E), suggesting that the fatty
acid-derived carbon atoms might be further used as an alterna-
tive carbon source.
To address whether the upregulation of FAO in quiescent
NSPCs is transcriptionally regulated, we measured the expres-sion levels of the Peroxisome proliferator-activated receptor
alpha (PPARa), a known transcriptional regulator of genes
involved in FAO by qRT-PCR (Leone et al., 1999). Indeed,
expression of PPARa and its target genes was highly upregu-
lated in quiescent NSPCs compared to proliferating NSPCs (Fig-
ures 2G and S2D), suggesting that upregulation of FAO upon
quiescence is at least partially regulated on a transcriptional
level. Given this transcriptional component of FAO regulationCell Reports 20, 2144–2155, August 29, 2017 2147
Figure 3. Cpt1a Is Expressed in Adult
NSPCs In Vivo
(A) Immunohistological analysis of a reporter
mouse expressing GFP under the Cpt1a promoter
reveals high GFP expression in the SGZ of the DG,
where NSPCs reside. Shown is a representative
image of a brain section from a 2-month-old
animal.
(B) Co-stainings for Cpt1a-GFP and the prolif-
eration marker Ki67 show that the majority of
proliferating NSPCs do not express GFP, sup-
porting the findings that FAO is specifically
upregulated in quiescent NSPCs. Shown is a
representative confocal image (maximum pro-
jection) from a 2-month-old Cpt1a-GFP reporter
mouse. Arrows indicate Ki67+/GFP cells; the
arrowhead points to a Ki67+/GFP+ cell. The bar
graph shows the percentage of GFP+ and GFP
NSPCs out of all Ki67+ cells in the SGZ of the
DG (mean ± SEM).
(C) Cpt1a-GFP-positive NSPCs are almost all
positive for the NSPC marker SOX2, and
GFP+ processes co-stain with the NSPC marker
Nestin. Shown is a representative confocal
image (maximum projection) from a 2-month-old
Cpt1a-GFP reporter mouse. Dotted lines show
the outline of the granular zone of the DG,
the boxed area is enlarged in the right panel.
The bar graph shows the percentage of GFP+
and GFP NSPCs out of SOX2+ cells (mean ±
SEM).
(D) Cpt1a-GFP-positive NSPCs are almost
all negative for the immature neuronal marker
Doublecortin (DCX), suggesting that FAO is
downregulated upon neuronal lineage commit-
ment. Shown is a representative confocal
image (maximum projection) from a 2-month-old Cpt1a-GFP reporter mouse. Dotted lines show the outline of the granular zone of the DG, the boxed area
is enlarged in the right panel. The bar graph shows the percentage of GFP+ and GFP NSPCs out of DCX+ cells (mean ± SEM).
Scale bars represent 200 mm (A), 50 mm (C and D, left), and 20 mm (B, C, and D, right).
See also Figure S3.through PPARa, we next assessed whether FAO gene expres-
sion could be modulated in proliferating NSPCs to reach similar
levels as in quiescent NSPCs and whether such an upregulation
would render proliferating NSPCs more quiescent. Treatment
with the PPARa agonist WY14643 indeed led to an upregulation
of FAO genes in proliferating NSPCs compared to control
NSPCs (Figure 2G and S2D), however, to a far lesser extent
than in quiescent NSPCs. Similarly, although modulation of
FAO genes by WY14643 significantly reduced proliferation
compared to control NSPCs, proliferation was still far higher
than in quiescent NSPCs (Figure 2F).
Cpt1a Is Expressed in Hippocampal NSPCs In Vivo
After identifying a role for FAO in NSPC quiescence in vitro, we
next analyzed the expression of Cpt1a within the adult hippo-
campal neurogenic niche using a Cpt1a reporter mouse
expressing GFP from the regulatory elements of the Cpt1a
genomic locus (Genesat; hereafter called Cpt1a-GFP) (Gong
et al., 2003). Besides GFP-positive classical astrocytes
throughout all hippocampal subfields (Figures 3A and S3B), we
found GFP expression to be highly enriched in the subgranular
zone (SGZ) of the DG (Figures 3A and S3A). GFP-positive cells2148 Cell Reports 20, 2144–2155, August 29, 2017expressed Cpt1a, as confirmed with staining against endoge-
nous Cpt1a (Figure S3C). Next, we phenotyped GFP-labeled
cells in Cpt1a-GFP mice and found that GFP expression prefer-
entially labeled non-mitotic, Ki67-negative hippocampal NSPCs
and only a small subset of cycling NSPCs (Figure 3B). Virtually all
Cpt1a-GFP-positive cells co-labeled with the radial and non-
radial NSPCmarker SOX2 (Figure 3C). Furthermore, the majority
of radial processes positive for the radial NSPC marker Nestin
were also GFP positive (83.7% ± 6.2%; Figure 3C). Cpt1a was
virtually absent in doublecortin (DCX)-expressing neuronal prog-
eny of hippocampal NSPCs (Figure 3D). Furthermore, Spot14
was co-expressed in Cpt1a-GFP-positive cells (Figures S3D
and S3E), suggesting that FAO is indeed high in NSPCs and be-
comes downregulated with neuronal differentiation.
Cpt1a Is Required for Proper Neurogenesis In Vivo
To directly test for a role of Cpt1a-dependent FAO for NSPCs
in vivo, we conditionally deleted Cpt1a specifically in adult quies-
cent NSPCs by crossing Cpt1a flox/flox mice (Cpt1a-conditional
knockout [cKO]) (Schoors et al., 2015) with mice harboring
tamoxifen (TAM)-inducible Spot14-driven Cre recombinase
(S14iCre) (Knobloch et al., 2013) and yellow fluorescent protein
(YFP) reporter alleles in the ROSA locus (R26YFP), inducing
recombination at seven weeks of age. The low recombination
efficiency of the S14iCre mouse line resulted in sparse labeling
of cells, allowing the identification and classification of labeled
progeny into potential clones according to their spatial clus-
tering, similarly to previously published analyses referred to as
clonal analysis (Bonaguidi et al., 2011). However, it needs to
be noted that the classification of cellular clusters into clones
according to spatial distance only assumes common lineage
and does not ultimately prove the presence of cells of clonal
origin as this would require an additional level of genetic lineage
tracing (e.g., through genetic bookmarking as previously used in
NSPCs; Fuentealba et al., 2015).
We first analyzed cell cluster size distribution 8 days after the
first TAM administration using the sparse labeling method and
found that size and composition of cellular clusters was not
significantly altered between control and Cpt1a-cKO mice,
although no larger clones were found in Cpt1a-cKO (Figures
S4A and S4D). At this time point, slightly lower numbers of clus-
ters were found in Cpt1a-cKO mice compared to control mice
(17 clones in 5 mice versus 24 clones in 4 mice), but the number
of YFP-positive cells per mouse was not significantly lower in the
Cpt1a-cKO mice compared to control mice (7.2 ± 4.5 versus 11
± 3.7; p > 0.1). Detailed cluster analysis did not reveal significant
changes (Figures S4B, S4C, and S4F), although a small decrease
in clones containing only R and a small, non-significant increase
in active clones in Cpt1a-cKO might be suggestive of an initial
activation upon Cpt1a-dependent knockout of FAO.
Next, we analyzed cell cluster composition and number
25 days after the first TAM administration. These analyses
revealed a dramatic decrease in the number of YFP-positive
cells per clone in Cpt1a-cKO mice compared to control litter-
mates (Figures 4A, 4B, and S4E). The majority of clones in the
Cpt1a-cKO mice contained only one to two cells, whereas
more than half of the clones in control mice were composed of
three to 12 or even more cells (Figures 4A, 4B, and S4E), sug-
gesting a massive impairment of NSPC expansion upon FAO
knockout. Furthermore, fewer clones were found in Cpt1a-cKO
mice compared to control mice (34 clones in seven Cpt1a-cKO
mice versus 62 clones in three control mice), and the number
of YFP-positive cells per mouse was significantly lower in the
Cpt1a-cKO mice compared to control mice (Cpt1a-cKO:
12.8 ± 5.8 versus 111 ± 65.6 in control mice; p < 0.05), implying
that FAO knockout leads to cell death. This was also reflected by
a decrease in the number of radial-glia like NSPCs in Cpt1a-cKO
compared to controls (Cpt1a-cKO: 2.6 ± 1.5 versus 17 ± 10.4 in
control mice; p = 0.06).
A detailed analysis of the clone compositions revealed an
increase in clones containing only one radial glia-like cell (R), a
reduction in clones containing an R and neural progeny (N), an
absence of clones containing a R, N and astrocytes (A), and an
increase in clones without a R in Cpt1a-cKO mice compared
to controls. Further, there was a strong reduction in the number
of active clones (containing a radial glia-like cell that generated
progeny) (Figures 4C–4D). Thus, genetic inhibition of FAO in
adult hippocampal NSPCs results in fewer recombined cells
indicative of cell death and smaller as well as less active clones
indicative of reduced cell proliferation, thus corroborating thein vitro results upon FAO inhibition. However, the detailed impact
of FAO on the specific cellular stage (quiescence, proliferation,
cell death, and survival) cannot be answered unambiguously
with these snapshot data. Given that FAO is used by both prolif-
erating and quiescent NSPCs in vitro (although the latter have
much higher FAO levels and dependmore on it), it is indeed likely
that the strong decrease in progeny generation upon FAO abla-
tion is due to an influence of FAO on several cellular stages.
Small hairpin RNA (shRNA)-mediated knockdown of Cpt1a
using in utero electroporation in the developing mouse cortex
at mid-neurogenesis (embryonic day 13 [E13]) corroborated
the importance of FAO for proper neurogenesis in vivo that has
been also previously shown by Xie et al. (2016) (Figures S4I
and S4J). Although NSPCs are more proliferative at this stage
compared to adulthood (Farkas and Huttner, 2008), staining
against endogenous Cpt1a confirmed that Cpt1a is also highly
enriched in NSPCs lining the ventricle during development (Fig-
ure S4H). 24 hours after electroporation (corresponding to E14)
(Figure S4J), proliferation at the apical surface was significantly
reduced upon Cpt1a knockdown, and general disorganization
of mitoses in the ventricular zone was observed (Figures S4K
andS4L). Furthermore, we found amassive increase in cell death
upon Cpt1a knockdown, as measured by the apoptotic marker
cleaved caspase-3 (Figure S4M), corroborating the in vitro
results.
Malonyl-CoA Levels Regulate NSPC Proliferation
Given the important role of FAO for NSPCs in vitro and in vivo,
determined by fully blocking this pathway with genetic and
pharmacological means, we next aimed to test the significance
of this regulatory pathway for NSPC activity in a more physio-
logical manner. Metabolic pathways are finely tunable through
substrate availability and intrinsic levels of metabolites have
been shown to determine pathway activity. Such shifts in
pathway activity are likely to reflect better the actual physiolog-
ical situation than switching off a pathway by genetic deletion of
its key players. For FAO, the metabolite malonyl-CoA functions
as the endogenous inhibitor of Cpt1a and serves at the same
time as a substrate for de novo lipogenesis, thus it has also
been termed a ‘‘rheostat’’ regulating these two lipid metabolic
pathways (Foster, 2012; McGarry and Brown, 1997). Thus, we
reasoned that elevating levels of malonyl-CoA decreases
Cpt1a-dependent FAO in a physiological way rather than
completely blocking it and provides sufficient substrate to fuel
FASN-dependent de novo lipogenesis that is required for
NSPC proliferation (Knobloch et al., 2013). However, it is not
known if malonyl-CoA can be taken up by cells when provided
extracellularly. Thus, we first tested if exogenously provided
malonyl-CoA can be metabolized and detected intracellularly.
We isolated lipids of proliferating, highly lipogenic NSPCs
(Knobloch et al., 2013) that were incubated with radioac-
tively labeled malonyl-CoA (14C-malonyl-CoA) for 48 hr (Fig-
ure S5A). We detected incorporation of 14C-malonyl-CoA in
polar lipids and triacylglycerides (TAGs, neutral lipids) (Fig-
ure S5B), clearly showing that exogenous malonyl-CoA
can indeed be utilized by NSPCs. Next, we tested if exoge-
nously applied malonyl-CoA could prevent BMP4-mediated in-
duction of NSPC quiescence. Adult NSPCs were exposed toCell Reports 20, 2144–2155, August 29, 2017 2149
Figure 4. Cpt1a Is Required for Proper Neurogenesis In Vivo
(A) Conditional Cpt1a knockout in adult quiescent NSPCs, by crossing Cpt1a flox/flox mice with Spot14-driven CreERT2 recombinase mice and ROSA YFP
reporter mice, leads to disturbed neurogenesis. Shown are representative confocal images (maximum projection) and a composite image showing the recon-
struction of individual clones fromCpt1a-cKOwild-type (WT)/WTmice (left) and Cpt1a-cKO flox/floxmice (right) 25 days after first TAM induction. The boxed area
is enlarged in the reconstruction panel.
(B) Clonal analysis reveals marked reduction in clone size in the Cpt1a-cKO flox/flox mice compared to Cpt1a-cKO WT/WT littermates.
(C) Detailed clone composition analysis shows a marked increase in clones containing only one radial glia-like cell (R), a great reduction in clones containing an
R and neural progeny (N), absence of clones containing anR, N, and astrocytes (A) and a slight increase in cloneswithout an R in Cpt1a-cKO flox/flox compared to
Cpt1a-cKO WT/WT.
(D) Active clones containing a radial glia-like cell (R) and any kind of progeny (X) are strongly reduced in Cpt1a-cKO flox/flox, suggesting that FAO is required to
allow proper neurogenesis.
(E) Representative confocal images of different types of recombined, YFP-positive cells from Cpt1a cKOWT/WTmice 25 days after the first TAM injection. Radial
glia-like cells (R) have a triangular-shaped soma (arrowhead) in the subgranular zone (SGZ) with a radial, arborized process into GCL (arrow) and are SOX2
positive. Neural progenitors (N) are non-radial cells with their soma in the SGZ (arrowhead), with one or more horizontal processes (arrows), sometimes still SOX2,
some already DCX positive. Immature neurons (N) have a round soma (arrowheads) in the granular cell layer (GCL) with a long vertical process (arrow), and are
usually DCX positive. Astrocytes (A) are multi-process-containing, star-shaped or bushy cells in the SGZ/Hilus or GCL.
Scale bars represent 50 mm (A) and 40 mm (E). nd, not detected. ***p < 0.001; **p < 0.01, +p = 0.086.
See also Figure S4.BMP4-containing medium in the presence of different concen-
trations of malonyl-CoA (Figure 5A). Indeed, elevated levels of
malonyl-CoA dose-dependently prevented the induction of2150 Cell Reports 20, 2144–2155, August 29, 2017quiescence, as measured using the cell cycle markers Ki67
and phosphorylated histone H3 (pH3) (Figure 5B). These data
show that manipulating FAO through malonyl-CoA levels is
Figure 5. Malonyl-CoA Levels Regulate NSPC Proliferation
(A–E) Manipulating the levels of the physiological, intrinsic Cpt1a inhibitor malonyl-CoA is sufficient to prevent NSPC quiescence and to induce proliferation under
quiescence conditions.
(A) Schematic outline of the experimental setup.
(B) Addition of malonyl-CoA (100 or 200 mM) at the beginning of quiescence induction is sufficient to prevent quiescence entry in a dose-dependent manner, as
revealed with the cell cycle marker Ki67 and the mitotic marker phospho Histone 3 (pH3). Shown are representative images of indicated doses and the quan-
tification of cycling and proliferating cells after 3 days of quiescence induction (mean ± SEM).
(C) Schematic outline of the experimental setup.
(D) Replating NSPCs after fully established quiescence in quiescence medium containing malonyl-CoA (100 or 200 mM) is sufficient to trigger cell cycle re-entry.
This suggests that malonyl-CoA levels can overrule the present quiescence cues. Shown are representative images of indicated doses and the quantification of
cycling and proliferating cells after three days of quiescence induction (mean ± SEM).
(E) Summary scheme of the described findings.
Scale bars represent 50 mm. ***p < 0.001; **p < 0.01, +p = 0.06.
See also Figure S5.sufficient to override BMP4-induced quiescence and keeps
NSPCs in a proliferating state.
Next, we induced BMP4-mediated quiescence over 3 days,
after which proliferation is almost completely inhibited, fol-
lowed by replating the cells in quiescence medium together
with malonyl-CoA (Figure 5C). Strikingly, we found that
malonyl-CoA triggered NSPCs to enter the cell cycle in a
dose-dependent manner, despite a fully established quies-
cence state and the continuous presence of quiescence cues(Figure 5D). This increased proliferation is most likely mediated
by an increase in FASN-dependent de novo lipogenesis, as
the addition of the FASN inhibitor Orlistat (Kridel et al., 2004)
into the BMP4-containing quiescence medium significantly
reduced remaining proliferation and abolished the pro-prolifer-
ative effect of malonyl-CoA when applied together with ma-
lonyl-CoA (Figures S5C and S5D). These data reveal that differ-
ential metabolic states are not a mere consequence of a given
stem cell state but that manipulating levels of FAO throughCell Reports 20, 2144–2155, August 29, 2017 2151
malonyl-CoA is instructive to regulate the behavior of adult
NSPCs (Figure 5E).
DISCUSSION
Due to its significance for brain function, understanding the
mechanisms regulating adult hippocampal neurogenesis is
important to advance the current knowledge of brain plasticity
in health and disease (Jessberger and Gage, 2014). In addition
to candidate-based approaches testing the role of well-studied
signaling pathways that had been implicated in regulating
embryonic neurogenesis such as Notch- and WNT-signaling, a
series of recent studies used unbiased approaches to charac-
terize gene expression profiles during distinct developmental
stages in the course of adult neurogenesis (Bracko et al., 2012;
Llorens-Bobadilla et al., 2015; Shin et al., 2015). These studies
all pointed toward an important role of cellular metabolism
and, more specifically, lipid metabolism in the regulation of the
neurogenic process in the adult brain. Supporting this, we
have previously shown that NSPCs in the adult brain depend
on FASN-dependent de novo lipogenesis for proper proliferation
and have identified Spot14, which is selectively expressed in
largely quiescent NSPCs, as the brake on de novo lipogenesis
(Knobloch et al., 2013, 2014). However, it remained unclear if
Spot14 merely suppresses de novo lipogenesis to keep NSPCs
in a quiescence state or if NSPC quiescence requires a special-
ized metabolic state.
We here used several complementary approaches in vitro
and in vivo to show that quiescent NSPCs rely on FAO and
that blocking this pathway pharmacologically or genetically
leads to massive disturbance of NSPC behavior. Using
in vitro approaches, we find clear evidence that inhibition of
FAO leads to enhanced cell death of quiescent cells but also
reduced proliferation. The conditional deletion of the rate-
limiting enzyme Cpt1a in vivo also results in fewer and smaller
cellular clusters, suggesting that the role for FAO in vivo resem-
bles the described function of cultured NSPCs in vitro. The
conditional deletion of Cpt1a in quiescent Spot14-positive
NSPCs using the Spot14-CreERT2 mouse line allowed us to
study the role of FAO on a specific NSPC population, reducing
possible side effects of altering FAO in astrocytes, as would
be the case by using other Cre-lines, such as GLAST-CreERT2
or Nestin-CreERT2 (Lagace et al., 2007; Mori et al., 2006).
However, the low recombination efficiency of the Spot14-
CreERT2-line results in sparse labeling, enabling clonal analysis,
but making assessments of proliferation or cell death with clas-
sical markers almost impossible. Thus, the detailed cellular ef-
fects (i.e., on exactly which stage FAO deletion exerts its main
phenotype) remain to be elucidated and will require novel ap-
proaches to study neurogenesis within the endogenous niche
such as chronic imaging.
Although glucose and lactate remain the main fuel sources
for the brain (Lundgaard et al., 2015; Wyss et al., 2011), our
data suggest that NSPCs might not only rely on these fuels.
We provide mechanistic evidence that oxidized fatty acids
are required for energy production and might serve as an alter-
native carbon source. Thus, our data reveal a metabolic shift in
adult hippocampal NSPCs that defines the change from a2152 Cell Reports 20, 2144–2155, August 29, 2017quiescent to a proliferative state. Interestingly, many metabolic
pathways are not only transcriptionally regulated but also high-
ly dependent on substrate availability and inhibitory feedback
loops of metabolic intermediates, providing a regulatory sys-
tem than can be finely tuned rather than an ‘‘on-off’’ system
(Lunt and Vander Heiden, 2011; Metallo and Vander Heiden,
2013). This is also the case for the breakdown and buildup of
lipids (Houten et al., 2016; Menendez and Lupu, 2007). A cen-
tral role in regulating the shift from FAO to lipogenesis appears
to be mediated by the levels of malonyl-CoA. This physiological
metabolite has been suggested to be a rheostat of stem cell
fate (Folmes et al., 2013), being both an inhibitor of Cpt1a
and a substrate for de novo lipogenesis (McGarry et al.,
1983; Menendez and Lupu, 2007). Strikingly, we have previ-
ously shown that Spot14, which is highly expressed in quies-
cent NSPCs, indirectly reduces the levels of available
malonyl-CoA and reduces lipid synthesis (Knobloch et al.,
2013). BMP4-induced quiescent NSPCs recapitulate these fea-
tures and show highly increased Spot14 levels and reduced
malonyl-CoA levels, providing optimal conditions for FAO.
Thus, our data support the hypothesis that malonyl-CoA acts
as a rheostat with Spot14 taking a key role in this regulatory
process (summarized in the graphical abstract). Our data
corroborate previous findings by Stoll and colleagues who
characterized the metabolic state of NSPCs in the subventric-
ular zone (SVZ) and found that NSPCs in the adult SVZ depend
on FAO for their proliferation as shown by infusing Etomoxir
(thus pharmacologically inhibiting FAO) into the adult brain
(Stoll et al., 2015). Interestingly, recent studies described a
role for FAO in other stem cell systems: hematopoietic stem
cells (HSCs) seem to require FAO to maintain their stem cell
potential through a PPAR-delta mediated pathway and inhibi-
tion of FAO leads to HSC exhaustion (Ito et al., 2012). Similarly,
quiescent muscle satellite cells are relying on FAO and pyru-
vate oxidation and undergo a metabolic shift toward glycolysis
once they become activated (Ryall et al., 2015). Furthermore, a
recent study has addressed the consequences of systemic
inborn errors of FAO on brain development and showed that
defects in FAO lead to enhanced progenitor generation and
subsequently to a reduced embryonic NSPC pool (Xie et al.,
2016). These studies emphasize the importance of FAO for
proper stem cell behavior and suggest shared regulatory path-
ways involving FAO between different somatic stem cell types.
Whether malonyl-CoA levels and Spot14 are the regulating
entities in other somatic stem cells remains to be elucidated.
Excitingly, our data show thatmetabolic changes in the course
of NSPC activation are not mere bystanders of other signaling
pathways or transcriptional programs, but are effective to
change NSPC behavior in vitro. Manipulating FAO through
changing the levels of a single metabolite, its endogenous inhib-
itor malonyl-CoA, is sufficient to instruct quiescent NSPCs to
enter cell cycle and to proliferate in vitro. Due to the short half-
life of malonyl-CoA at 37C (72 hr), in vivo experiments are
currently not feasible. In contrast to the detrimental effects
seen when completely switching off FAO genetically or pharma-
cologically, alteration of endogenous metabolite levels might
better reflect the physiological relevance of metabolic shifts.
Given the instructive role of metabolism on NSPC quiescence
and proliferation behavior, manipulations of the metabolic state
may thus represent a novel approach to achieve enhanced
neurogenesis in the aging brain or in disease states where
NSPC activity is reduced.
EXPERIMENTAL PROCEDURES
Further details and an outline of the resources used in this work can be found in
the Supplemental Experimental Procedures.
Mouse strains used were Cpt1a-EGFP reporter mice (STOCK Tg(Cpt1a-
EGFP)IP41Gsat/Mmucd, MMRRC), Cpt1a cKO mice (Schoors et al., 2015),
Spot14CreERT2 mice (S14iCre) Knobloch et al., 2013), ROSA26 YFP reporter
mice (R26YFP), and C57/Bl6 mice (Janvier). All animal experiments were per-
formed according to Swiss regulatory standards and approved by the Veteri-
nary office of the Canton of Zurich. Cre-mediated recombination was induced
by intraperitoneal injections of tamoxifen (180 mg/kg) at the age of 6 to
7 weeks. Lentiviral constructs were designed and viruses produced as previ-
ously described (Knobloch et al., 2013). Adult mouse DGNSPCswere cultured
in DMEM with Ham’s F12, supplemented with N2 supplement plus epidermal
growth factor (EGF), fibroblast growth factor, and heparin (Knobloch et al.,
2013; Ray and Gage, 2006). Quiescence was induced over three days replac-
ing EGF with BMP4, as previously described (Martynoga et al., 2013; Mira
et al., 2010). For Cpt1a inhibition, Etomoxir or malonyl-CoA was added to
the medium as outlined in the figures. Proteomic analysis was done according
to previously established protocols (Wisniewski et al., 2009). Radioactive FAO
measurements were done using labeled 3H-palmitic acid and 14C-palmitic
acid, and the amount of tritiated water or 14CO2 generated was assessed
(Djouadi et al., 2003; Huynh et al., 2014). Quiescent and proliferating NSPCs
were collected for RNA and protein isolation, and established protocols
were used for subsequent processing and analysis (Knobloch et al., 2013).
In utero electroporation of Cpt1a and control shRNA plasmid DNA into mouse
embryos (embryonic day 13 [E13]) was carried out as described previously
(Asami et al., 2011). For immunohistochemical analyses, brain tissues were
sectioned, stained, and imaged using previously published methods (Bona-
guidi et al., 2011; Knobloch et al., 2013). Mass spectrometry measurements
to assess the amount of malonyl-CoA and to determine the energy charge
were done with cellular extracts using liquid chromatography-tandem mass
spectrometry LC-MS/MS (Knobloch et al., 2013; Schoors et al., 2015). To
analyze C13 incorporation, quiescent and proliferating NSPCs were incubated
24 hr prior to collection/extraction with 13C-palmitic acid and analyzed with
gas chromatography-mass spectrometry (GC-MS) as previously described
(Schoors et al., 2015). Statistical analysis was performed using unpaired
t tests, paired t tests, and one-way-ANOVA or two-way-ANOVA, followed by
Holm-Sidak’s multiple comparisons tests. Significance levels are set at
p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2017.08.029.
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Figure S1 (related to Figure 1): Quiescent NSPCs have a high rate of fatty 
acid oxidation (FAO). A) Representative images of reversible BMP4-induced 
quiescence in NSPCs. Shown are NSPCs kept under proliferating conditions 
(prol), after 3 days of quiescence induction (quie), proliferating NSPCs that were 
	 2 
replated into proliferation medium (prol replated) and previously quiescent 
NSPCs that were replated into proliferation medium and kept for 3 days under 
proliferation conditions (ex quie replated). B) Flow cytometry histograms showing 
the DNA profile of proliferating (prol) and quiescent (quie) NSPCs and of 
previously quiescent NSCPs that have been replated into proliferation medium 
for 3 days (ex quie 3d) or 6 days (ex quie 6d). The corresponding proliferating 
control NSCPs were replated accordingly (prol repl. 3d and prol repl. 6d). Three 
days of quiescence treatment significantly decreases the amount of proliferating 
cells. Replating quiescent NSPCs into proliferation medium induces cell 
proliferation, showing the reversibility of this in vitro quiescence. Although 3 days 
re-exposure to proliferation medium led to a very similar proliferation profile as 
seen in NSPCs not exposed to quiescence, there were still significant differences, 
which were gone after 6 days of re-exposure to proliferation medium. Bars 
represent mean ± SEM. C) The neurogenic potential upon differentiation was not 
altered upon previous quiescence exposure, further demonstrating the 
reversibility of the system. Shown are representative images of NSPCs that were 
allowed to spontaneously differentiate for 9 days upon growth factor removal. 
Prior to differentiation, NSPCs were either exposed 3 days to quiescence cues 
followed by 3 days proliferation medium (ex quie-diff) or kept all the time under 
proliferation conditions (prol-diff). Map2ab marks neurons. Quantification 
represents mean ± SEM. D) Comparative analysis of the proteome of 
proliferating and quiescent NSPCs reveals proteins involved in FAO to be 
enriched in quiescent NSPCs. The dot plot shows proteins changed significantly 
	 3 
at least two fold (log2 ≥ |1|) in quiescent (red) and proliferating (green) NSPCs. E) 
Shown is the median abundance of proteins belonging to the represented GO 
terms. Only the GO term “Fatty acid oxidation” was changed more than 2 fold 
(median higher than log2 ≥ |1|). F) Histograms show the normalized abundance of 
proteins belonging to the indicated GO terms, detected in the mass spectrometric 
comparison of proliferating and quiescent NSPCs. (Gray = expression change of 
log2 < |1|, red = expression change of log2 ≤ -1, enriched in quiescent NSPCs, 
green = expression change of log2 ≥ 1, enriched in proliferating NSPCs). G) 
Acetyl-CoA does not differ significantly between quiescent and proliferating 
NSPCs, as measured by mass spectrometry (mean + SEM). H) Cpt1a in 
proliferating NSPCs co-localizes with the mitochondrial marker Mitotracker. 
Shown are representative confocal images of maximum projections of individual 
channels and a 3D-reconstruction.  




Figure S2 (related to Figure 2): Pharmacological blocking of FAO in 
proliferating NSPCs decreases proliferation. A) Time-lapse analysis of 
proliferating NSPCs exposed to various doses of the irreversible Cpt1 inhibitor 
Etomoxir (50, 100 and 200µM). Shown are a schematic outline of the 
experimental setup, the quantification of the area covered by proliferating NSPCs 
over time, and representative images. The quantification of the percent area 
covered by proliferating NSPCs reveals a significant decrease in proliferation for 
all doses tested. B) Flow cytometry-based cell cycle analysis confirms a 
decrease in proliferation with Etomoxir in proliferating NSPCs. Shown are 
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Histograms of DNA profiles after 24h of exposure with the indicated doses of 
Etomoxir (50 and 100µM) and the corresponding quantification (left bar graph). 
Right bars show the percentage of cells in Sub-G1 as a readout for cell death. 
100µM Etomoxir lead to a mild but significant increase in cell death. C) The 
decrease in proliferation upon Etomoxir treatment is also apparent using an EdU-
pulse to label cells in S-phase. With 50µM or 100µM Etomoxir for 24h, the 
amount of proliferating NSPCs decreased significantly, whereas the increase in 
cell death (cleaved caspase-3) was mild and non-significant. Shown are 
representative images of the different conditions and quantification of 
proliferation and cell death. D) Treatment with the PPARα agonist WY14643 led 
to an upregulation of PPARα target FAO genes in proliferating NSPCs compared 
to control NSPCs, however, to a far lesser extent than in quiescent NSPCs. 
Shown are the mRNA expression levels (mean fold change ±	 range) of 
multifunctional protein 1 (Mfp1), 	 Acyl-CoA oxidase 1 (Acox1), peroxisomal 3-
ketoacyl-CoA thiolase A (Acaa1a) and peroxisomal biogenesis factor 11 alpha 
(Pex11a).  






Figure S3 (related to Figure 3): Cpt1a is expressed in quiescent NSPCs in 
vivo and co-labels with the quiescence marker Spot14. A) DAB-staining 
against GFP on a sagittal section of a 2-month-old Cpt1a-GFP reporter mouse. 
B) Co-staining for Cpt1a-GFP and for glial fibrillary acidic protein (GFAP) shows 
	 7 
that GFP positive cells outside the subgranular zone of the DG are astrocytes. 
Shown is a representative confocal image (maximum projection) from a 2-month-
old Cpt1a-GFP reporter mouse. Dotted lines show the outline of the granular 
zone of the DG. C) Co-staining for Cpt1a-GFP and endogenous Cpt1a protein 
shows that the Cpt1a-GFP reporter mouse faithfully reports Cpt1a expression. 
Shown is a representative confocal image (maximum projection) from a 2-month-
old Cpt1a-GFP reporter mouse. Dotted lines show the outline of the granular 
zone of the DG. D) Co-staining for Cpt1a-GFP and endogenous Spot14 protein 
reveals that NSPCs expressing Spot14 are also positive for GFP. Shown is a 
representative confocal image (maximum projection) from a 2-month-old Cpt1a-
GFP reporter mouse. Dotted lines show the outline of the granular zone of the 
DG. Note the increase in GFP signal due to harsh epitope retrieval needed for 
Spot14 staining. E) Enlarged image of the boxed area depicted in D.  




Figure S4 (related to Figure 4): Cpt1a is required for proper neurogenesis in 
the adult and during development. A) Conditional Cpt1a knockout in adult 
quiescent NSPCs, by crossing Cpt1a flox/flox mice with Spot14-driven Cre 
recombinase mice and ROSA YFP reporter mice. Clonal analysis early after TAM 
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induction (8 days after the first injection) does not yet reveal significant 
differences in clone size in the Cpt1a-cKO flox/flox mice compared to Cpt1a-cKO 
wt/wt littermates. B) Detailed clone composition analysis shows no significant 
differences at 8 days after induction, although there was a small decrease in 
clones containing only R. C) The number of active clones early after deletion of 
Cpt1a is not different between Cpt1a-cKO flox/flox mice compared to Cpt1a-cKO 
wt/wt littermates despite a small, but non-significant (n.s.) increase (p = 0.17) in 
active clones containing a radial glia-like cell (R) and any kind of progeny (X) in 
Cpt1a-cKO mice. D) Clone size distribution 8 days after induction, analyzed per 
mouse instead of per clones (mean ± SEM). Similar to the data shown in A, there 
is no significant difference at that timepoint. E) Clone size distribution 25 days 
after induction, analyzed per mouse instead of per clones (mean ± SEM). Similar 
to the data shown in Fig. 4B, there is a significant reduction in the number of 
large clones in Cpt1a-cKO flox/flox mice compared to Cpt1a-cKO wt/wt 
littermates.  F) The number of active clones analyzed per mouse instead of per 
clones (mean + SEM) does not reveal a significant difference 8 days after 
induction. G) The number of active clones analyzed per mouse instead of per 
clones (mean ± SEM) at 25 days after induction shows a significant reduction in 
Cpt1a-cKO flox/flox mice compared to Cpt1a-cKO wt/wt littermates, similar to the 
data shown in Fig. 4D. H) During development, Cpt1a is expressed in the 
ventricular zone, where NSPCs reside and give rise to newborn neurons. Shown 
is a representative confocal image (maximum projection) of an E14 wildtype 
mouse embryo brain stained against Cpt1a (cytoplasm) and Sox2 (nuclei). I) A 
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shRNA targeting Cpt1a was tested for knockdown efficiency compared to a non-
targeting control shRNA. All constructs also contain a mCherry reporter 
sequence. Shown is a representative Western blot of the endogenous Cpt1a 
levels in Hepa1-6 cells 48h after shRNA-transfection and the corresponding 
loading control (β-actin). The bar graph shows the quantification of Cpt1a levels 
normalized to β-actin (mean ± SEM). J) ShRNA-mediated Cpt1a knockdown in 
vivo by in utero electroporation. Shown is a scheme of the experimental 
approach: ShRNA constructs were injected into the ventricle of E13 mouse 
embryos and current was applied to transfect cells in the ventricular zone. 
Embryos were analyzed one day later (E14) by immunohistochemistry. K) 
Representative images of embryonic brain sections after in utero electroporation 
with a non-targeting shRNA and a shRNA against Cpt1a, both expressing 
mCherry. Staining against the proliferation marker phospho-histone 3 (pH3) 
reveals reduced proliferation at the apical surface, where radial glia divide, and a 
general disorganization of the ventricular zone. L) Quantification of the pH3 
intensity from the apical surface 40µm into the ventricular zone. M) 
Representative images of embryonic brain sections after in utero electroporation 
of the different shRNA-constructs described in D. Dotted lines show the 
transfected areas in the cortex marked by mCherry expression. Staining against 
the apoptotic marker cleaved Caspase-3 reveals massive cell death upon 
knockdown of Cpt1a, suggesting that FAO is also required for proper 
neurogenesis during development. Enlarged images of the mCherry positive 
transfected areas show the apparent morphological differences between non-
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targeting shRNA transfected NSPCs and the NSPCs transfected with the Cpt1a 
targeting shRNA. I) Quantification of the increase in cleaved Caspase 3 positive 
area upon Cpt1a knockdown in utero (mean ± SEM). 






Figure S5 (related to Figure 5): Exogenously applied malonyl-CoA is 
incorporated into new lipids and increased proliferation upon malonyl-CoA 
exposure in quiescent NSPCs is at least partially regulated by an increase 
in FASN-dependent de novo lipogenesis. A) Scheme of the experimental 
procedure to detect whether exogenously applied malonyl-CoA can be used by 
NSPCs. Radioactively labeled malonyl-CoA (14C-malonyl-CoA) was applied 
together with non-labelled malonyl-CoA (100µM) to proliferating NSPCs for 48h. 
Intracellular lipids were isolated, separated by thin layer chromatography and 
their radioactivity was measured by scintillation counts. B) Both in the polar lipid 
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fraction (containing the phospholipids) and in the neutral lipid fraction (containing 
triacylglycerides), significantly higher radioactivity (decay per minute, dpm) was 
detected in the samples incubated with 14C-malonyl-CoA, indicating that 
exogenously applied malonyl-CoA is taken up and integrated into newly 
synthesized lipids in NSPCs.  C) NSPCs were replated after fully established 
quiescence in quiescence medium containing either vehicle, the FASN inhibitor 
Xenical (Orlistat, 20 µM), malonyl-CoA (200 µM) or both Xenical and malonyl-
CoA (20 µM and 200 µM). D) The number of mitotic cells was analyzed 3 days 
later by pH3 staining. Inhibition of FASN significantly reduced the remaining 
small percentage of mitotic cells, whereas malonyl-CoA significantly increased 
proliferation. Xenical abolished the pro-proliferative effect of malonyl-CoA when 
applied together with malonyl-CoA. This suggests that increased proliferation of 
quiescent NSPCs is at least partially dependent on FASN-driven de novo 
lipogenesis. Shown are representative images of indicated doses (A) and the 
quantification of proliferating cells (B) (mean ± SEM).  
Scale bar represents 50µm. ***p < 0.001, **p < 0.01, * p < 0.05. 
 
EXTENDED DATA TABLES 
 
Table 1. Listed are the normalized abundances of proteins detected in the mass 
spectrometric comparison of proliferating and quiescent NSPCs.  
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Table 2.  Listed are the normalized abundances of significantly and at least two-
fold changed proteins, belonging to different GO processes.  
 




SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
mouse anti-pH3 Abcam #14955 
mouse anti-Cpt1a Abcam #ab128568 
rabbit anti-Ki67 Novocastra #NCL-Ki67p 
chick-anti-GFP Aves #GFP.1020 
goat anti-Sox2 Santa Cruz #sc17320 
mouse anti-Nestin BD Biosciences #556309 
goat anti-DCX Santa Cruz #sc 8066 
mouse anti Map2ab Sigma #M2320 
chick anti-GFAP Aves #GFAP 
mouse-anti GFAP Sigma #032M4779 
rabbit anti-Spot14 Abcam #Ab56193 
rabbit anti-cleaved Caspase-3 Cell signaling #Asp175 
rabbit anti-dsRed Living colors #632496 
mouse anti-beta-actin Sigma #A2228 
Mitotracker Deep red Invitrogen #M22426 
DAPI Sigma #D9542 
   
Biological Samples 
   
Chemicals, Peptides, and Recombinant Proteins 
Tamoxifen Sigma #T5648 
Corn-oil Sigma # C8267 
N2 supplement Gibco #17502048 
hEGF Peprotech #AF-100-15-500ug 
hFGF basic Peprotech #100-18B-500ug 
antibiotic/antimycotic Thermo Scientific #15240-062 
Heparin Sigma #H3149-50KU 
Poly-ornithine Sigma #P36655 
Laminin Sigma # L2020 
mouse BMP4 R&D Systems #5020-BP-010 
Trypsin Gibco  #15090 
Versene Gibco #15040-033 
Ovomucoid trypsin inhibitor Sigma #T6522 
DNAse I type IV Sigma #D5025-15 KU 
Malonyl-CoA Sigma #M4263 
Etomoxir Sigma #E1905 
Xenical (Orlistat) Roche Xenical 120 mg 
Hoechst 33342 Invitrogen #H3570 
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Wy14643 Enzo Life Sciences #	BML-GR200-0250 
Lipofectamine-2000 Thermo Scientific #11668019 
Complete EDTA-free proteinase Inhibitor tablets Roche #11873580001 
[9,10-3H(N)]palmitic acid PerkinElmer #NET043001MC 
[1-14C]palmitic acid PerkinElmer #NEC075H050UC 
fatty acid-free albumin Sigma #A8806 
sodium palmitate Sigma #P9767 
L-carnitine Sigma #C0158 
C13-labelled palmitate  Cambridge Isotope 
Laboratories Inc. 
#CLM-3943 
DOWEX 1X2 chloride form resin (200-400 mesh) Sigma #217395 
IRGASAFE Plus, scintillation liquid Zinser Analytic #1003100 
   
Critical Commercial Assays 
Click-iT EdU Imaging Kit Invitrogen #C10338 
BCA Protein determination Pierce #23225 
BC assay  Uptima #FT-40840A 
Vectastain ABCKit Vector Laboratories #PK-6100 
Nucleo Spin RNAII Kit  Macherey & Nagel #740955 
Superscript III Kit  Invitrogen #18080093 
   
Deposited Data 
Raw and analyzed Proteomics Data This paper PXD005598 
   
Experimental Models: Cell Lines 
Mouse: primary dentate gyrus NSPCs (Ray and Gage, 2006) N/A 
Mouse: liver hepatome cells (Hepa1-6 cells) Leibniz Institute DSMZ  #ACC 175 
   
Experimental Models: Organisms/Strains 
Mouse: Tg(Cpt1a-EGFP)IP41Gsat/Mmucd MMRRC # 030281-UCD 
Mouse: C57BL/6JRj wildtype mice Janvier #C57BL/6JRj 
Mouse: Cpt1a cKO mice (Schoors et al., 2015) N/A 
Mouse: Spot14CreERT2 mice (S14iCre) (Knobloch et al., 2013) N/A 
Mouse: B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J 
(R26YFP) 
Jackson laboratory #006148 
Mouse: S14iCre x Cpt1a cKO x R26YFP This paper N/A 
   
Recombinant DNA 
Cpt1a shRNA1 5’-3’: 
CCGGCGTGAGGAACTCAAACCTATTCTCGAGAATA
GGTTTGAGTTCCTCACGTTTTTG (targeting Cpt1a 
from nucleotide 949-969) 
This paper N/A 
Non-targeting shRNA 5’-3’: 
TCCTAAGGTTAAGTCGCCCTTTCAAGAGAAGGGCG
ACTTAACCTTAGGTTTTTTC 
This paper N/A 
LentiLox3.7 U6 shRNA (pLL3.7) Addgene #11795 
LentiLox3.7 mcherry U6 shRNA (Knobloch et al., 2013) N/A 
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Sequence-Based Reagents 
Primers for qPCR This paper See Table 3 
   
Software and Algorithms 
Imaris Bitplane www.bitplane.com 
ImageJ NIH Image https://imagej.net/ 
Free-D  Free-D http://free-
d.versailles.inra.fr/ 
Photoshop Adobe www.adobe.com 
Progenesis QI for proteomics Nonlinear Dynamics http://www.nonlinear.
com/progenesis/qi-
for-proteomics/ 
Scaffold 4  Proteome Software http://www.proteome
software.com/produc
ts/scaffold/ 
Metacore 6.24 build 67895  Thomson Reuters www.thomsonreuter
s.com 
Xcalibur software  Thermo Scientific OPTON-30487 






CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed 




EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Animals 
Mice were kept in a specific pathogen free (SPF) animal facility according to the 
guidelines of the Federation of European Laboratory Animal Science 
Associations (FELASA), where persons entering the facility must wear protective 
cloths, facemasks, hairnets and gloves after crossing a barrier. Mice were kept 
with littermates under a 12h dark/light cycle in individually ventilated cages and 
with ad libitum access to food and water. The Cpt1a-EGFP reporter mouse line 
(STOCK Tg(Cpt1a-EGFP)IP41Gsat/Mmucd) was generated by the Mutant 
Mouse Regional Resource Centers (MMRRC). Founders were cryo-resuscitated 
and bred thereafter with C57BL/6JRj wildtype mice (Janvier Labs, France). 
Genotyping was performed using 5’-CTGGTGCCAGGCTTCTAA-3’ forward and 
5’-TAGCGGCTGAAGCACTGCA -3’ reverse primers. Six females were used for 
histological analyses at the age of two months. For in utero electroporation 
experiments, time-mated C57BL/6JRj female mice were obtained from Janvier 
Labs (France). Cpt1a cKO mice (Schoors et al., 2015) were embryo-transferred 
	 19 
through C57BL6/J (Jackson laboratory) and kept thereafter on a heterozygous 
level by crossing them with C57BL/6JRj (Janvier Labs, France). They were 
crossed with Spot14CreERT2 mice (S14iCre (Knobloch et al., 2013)) and 
ROSA26 YFP reporter mice (R26YFP, B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J, 
kept for more than 10 generations on a C57BL/6J background) to obtain S14iCre 
+/-; Cpt1a cKO wt/wt; R26YFP fl/wt and S14iCre +/- ; Cpt1a cKO fl/fl; R26YFP 
fl/wt littermates. Breedings were set up in a way that all the genotypes were 
generated within one litter and that several litters were born within one week. 
Littermates were assigned to the different groups based on genotype. Due to low 
recombination efficiency, Cre-mediated recombination was induced by five 
intraperitoneal injections of tamoxifen on five consecutive day (Sigma, 180mg/kg, 
dissolved in cornoil) at the age of six to seven weeks. All animals received 
tamoxifen. Animals were perfused either eight days or twenty-five days after first 
tamoxifen injections. For the eight day timepoint, one male and three females of 
S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt and one male and five females of 
S14iCre +/- ; Cpt1a cKO fl/fl; R26YFP fl/wt were induced. One S14iCre +/- ; 
Cpt1a cKO fl/fl female had to be excluded from the analysis, as no YFP positive 
cells were detected in the DG. For the twenty five day timepoint, two males and 
three females of S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt and one male and 
six females of S14iCre +/- ; Cpt1a cKO fl/fl; R26YFP fl/wt were induced. Two 
S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt (one male, one female) had to be 
excluded from the analysis, as no YFP positive cells were detected in the DG. 
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All animal experiments were performed according to Swiss regulatory standards 
and approved by the Veterinary office of the Canton of Zurich. 
 
Cells  
Primary adult mouse DG (mDG) NSPCs were obtained and cultured as 
previously described (Knobloch et al., 2013; Ray and Gage, 2006). In brief, DGs 
from eight female C57BL6/J (Jackson laboratory) were subdissected and 
processed as described (Ray and Gage, 2006). Early passages were frozen and 
kept in liquid nitrogen. Experiments were performed with cells up to passage 20. 
Mycoplasma tests were performed on a regular base to verify that cells were 
mycoplasma free. Mouse liver hepatome cells (Hepa1-6 cells) were grown as 
suggested by the provider, Leibnitz Institute DSMZ (Catalogue code: ACC 175). 
 
Plasmids  
Cpt1a shRNA sequence was designed using the RNAi Consortium hairpin 
candidate sequences selection (www.broadinstitute.org/rnai/trc) against mouse 
Cpt1a (NM_013495). The sequences of the oligonucleotides used are as follows: 
Cpt1a shRNA1 5’-3’: 
CCGGCGTGAGGAACTCAAACCTATTCTCGAGAATAGGTTTGAGTTCCTCAC
GTTTTTG (targeting Cpt1a from nucleotide 949-969) 




The shRNA knockdown constructs (derived from LentiLox3.7) were cloned to 





Cell culture  
Primary mDG NSPCs were kept as monolayer cultures in DMEM/F12 Glutamax 
medium supplemented with N2 (Invitrogen), human EGF (20 ng/ml), human 
basic FGF-2 (20 ng/ml, Peprotech) and Heparin (5mg/ml, Sigma). Medium 
contained an antibiotic/antimycotic (Anti-Anti, Thermo Fisher Scientific). This 
proliferation medium was changed every 2-3 days.  
For all experiments involving quiescence induction and/or 
immunocytochemistry, cells were plated on glass coverslips or multi-well cell 
culture dishes coated with Poly-L-ornithine (Sigma, 10µg/ml for plastic, 50µg/ml 
for glass) and Laminin (Invitrogen, 5µg/ml). All experiments were done with a 
minimum of 3 coverslips per condition.  
Quiescence was induced as previously described (Martynoga et al., 2013; 
Mira et al., 2010). In brief, exchanging EGF with recombinant mouse BMP4 (RnD 
Systems) results in a significant drop in proliferation over the course of 3 days 
with almost no more proliferation detectable after 3 days. This artificial 
quiescence is fully reversible after replating NSPCs in proliferation medium. For 
all quiescence experiments, cells were plated in proliferation medium (~40’000 
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cells/cm2) and switched the next day to quiescence medium, which was 
composed of DMEM/F12 Glutamax supplemented with N2, human basic FGF-2 
(20 ng/ml), Heparin (5mg/ml) and BMP4 (50ng/ml, BMP4 stock dissolved in 4mM 
HCL/PBS/0.5%BSA). Cells were kept for a minimum of 3 days in quiescence 
medium before fixation or harvest. For comparisons with proliferating NSPCs, 
cells were plated in parallel at a lower density (~14’000 cells/cm2) and kept in 
proliferation medium over the same time period as the quiescent NSPCs, with 
medium change every 2 days. To reverse quiescence, NSPCs were collected 
after 3 days of quiescence and replated in fresh proliferation medium (~50’000 
cells/cm2). To compare the proliferation rate of formerly quiescent NSPCs to cells 
that had not entered quiescence, proliferating NSPCs that were grown in parallel 
were also replated in fresh proliferation medium at slightly lower density (~30’000 
cells/cm2). For extended reversal of quiescence (6 days proliferation medium 
after quiescence), cells were replated as described above and split again 3 days 
later. For the experiments were effects of compounds on quiescence were tested 
cells were treated as followed: full quiescence was established as described 
above for 3 days, cells were washed off the plate with old medium, trypsinized 
with 2.5% Trypsin diluted to .05% in Versene (Invitrogen) and blocked with a 
trypsin Inhibitor Mix (L-15 medium, 0.1% ovomucoid trypsin inhibitor (Sigma), 
0.05% BSA and 0.01% DNAse I type IV). Cells were spun down in PBS, counted 
and plated onto freshly coated plates in fresh quiescence medium (~220’000 
cells/cm2). 100 µM or 200 µM Malonyl-CoA (Sigma) was added as outlined in the 
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corresponding figures. 20 µM Orlistat (Xenical, Roche) was used as previously 
described (Knobloch et al. 2013). 
For cell cycle analysis, two different methods were used. Cells were either 
harvested and stained in a fluorochrome solution (0.1% sodium citrate, 0.1% 
Triton X-100 and 50mg/L Propidium iodide) for 1h at 4°C or incubated live for 
30min at 37°C (in the cell culture incubator) with Hoechst 33342 (Invitrogen, 1: 
2000) Flow cytometry was performed on a LSRII instrument (Becton Dickson) 
and data were analysed using FlowJo software (Tree Star, Inc.). For Cpt1a 
inhibition, various doses of Etomoxir (50-200µM, Sigma) or Malonyl-CoA (100-
200µM, Sigma) were added to the medium as outlined in the main figures.  
The PPARα agonist Wy14643 (Enzo Life Science) was dissolved in 100% 
EtOH and 100µM was added to proliferating NSPCs for 48h. The same amount 
of 100% EtOH was added to proliferating NSPCs as a control. After 48h, cells 
were either collected for RNA isolation (see below) or incubated with EdU (5-
ethynyl-2’-deoxyuridine, Invitrogen, 10µM, 1h pulse at 37°C in cell culture 
incubator), fixed and processed for immunocytometry as described below. 
To assess the knockdown efficiency of the Cpt1a-shRNA construct, 
mouse liver hepatoma cells (Hepa 1-6 cells) that naturally express high Cpt1a 
levels were transfected with the 2 different constructs, using lipofectamine-2000 





Time-lapse imaging and analysis 
For time-lapse imaging, NSPCs were plated as described above in coated plastic 
cell culture plates in triplicates for each condition. Cells were placed in a heated 
and CO2-controlled chamber of an inverted microscope (Zeiss, Axio Observer) 
and 4-6 adjacent areas were imaged every 4h. Stitched phase contrast images 
were analysed using ImageJ. Several processing steps (bandpass filtering, 
Gaussian blurs, thresholding) were used to automatically analyze the area 




Proliferating and quiescent NSPCs were cultured as described above on coated 
10cm plates. Prior to protein extraction cells were washed twice using 4°C cold 
PBS (Life Technology).  Cells were lysed using 300µl lysis buffer (150mM NaCL, 
50mM Tris, 5mM EDTA, 20mM N-Ethylmaleimide, 2mM PMSF, 1x Complete 
EDTA-free proteinase Inhibitor tablets, ROCHE). Lysates were collected in 
precooled screw cap tubes (Sarstedt). Lysates were supplemented with 1.7% 
Triton (Sigma) and 1% Chaps (Sigma) and incubated for 1h with end over end 
rotation at 4°C.  Lysates were cleared by centrifugation at 17000g for 10min and 
protein concentration was determined using Protein DC assay (Biorad) following 
the Manufacturer’s instructions. 100µg protein was precipitated twice by 
methanol/chloroform precipitation and protein pellets were resuspended in SDS 
lysis buffer (4% (w/v) SDS, 100mM Tris/HCL pH 8.2, 0.1M DTT) and stored at -
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80°C. Protein samples were processed using a modified protocol by filter aided 
sample preparation (FASP) (Wisniewski et al., 2009). In brief, samples were 
incubated for 5 min at 95°C with 700 rpm shaking on a head block (Eppendorf), 
followed by 10min sonication. Protein concentration was measured using a Qubit 
2.0 Fluorometer (Thermo Fisher Scientific) following the Manufacturer’s 
instructions and 20µg protein per sample was used for further processing. 
Samples were mixed with 200µl 8 M urea in 100mM Tris/HCl pH 8.2 (UA) and 
loaded to Microcon-30 centrifugal filter units (Millipore), washed once with 200µl 
UA, alkylated with 100µl 50mM Iodoacetamide and incubated for 1min at 600rpm 
in a Thermo mixer (Eppendorf). Filter units were washed 3x with 100µl UA and 
2x with 100µl 0.5M NaCl. Filter units were then transferred to new collection 
tubes and incubated with 120µl TEAB with trypsin (1:50 (w/w) ratio of trypsin to 
protein) (Promega) overnight in a wet-chamber. If not otherwise stated, all 
centrifugation steps were performed for 20 min at RT. Samples were collected 
and acidified to a final concentration of 0.5% TFA followed by Solid Phase 
Extraction (SPE) C18 clean up. Finisterre SPE columns (100mg/1ml; WICOM 
International) were pre-wetted with 1ml 100% MeOH and cleaned with 1ml of 
60% ACN, 0.1% TFA before equilibration with 3% ACN, 0.1% TFA. The volume 
of peptide containing samples was adjusted to 500µl with 3% ACN 0.1% TFA 
and loaded onto SPE columns and washed twice with 1ml of 3% ACN, 0.1% TFA. 
Peptides were eluted with 60% ACN, 0.1% TFA, completely dried (Centrivap, 
Labconco) and dissolved in 3% ACN; 0.1% FA). Prior to measurements, peptide 
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samples were supplemented 1:40 with Retention Time Normalization Peptides 
(BIOGNOSYS). 
 
LC MS/MS analysis 
All data was acquired on an Orbitrap Fusion Tribrid mass spectrometer (Thermo 
Scientific, San Jose, Ca), which was connected to an Easy-nLC 1000 HPLC 
system (Thermo Scientific). 4µl of the peptide samples were loaded onto a frit 
column (inner diameter 75µm, length 15 cm) packed with reverse phase material 
(C18-AQ, particle size 1.9µm, pore size 120 Å, Dr. Maisch GmbH, Germany), 
and separated at a flow rate of 250nl per min. Solvent composition of buffer A 
was 0.1% formic acid in water, and buffer B contained 0.1% formic acid in 
acetonitrile. The following LC gradient was applied: 0 min: 3% buffer B, 50 min: 
25% B, 60 min: 32% B, 70 min: 97% B, 80 min: 97% B. Survey scans were 
recorded in the Orbitrap mass analyzer in the range of m/z 300-1500, with a 
resolution of 60000 and a maximum injection time of 100 ms. Higher energy 
collisional dissociation (HCD) spectra were acquired in the ion trap, using a 
maximum injection time of 35 ms. The precursor ion isolation width was set to 
m/z 2.0, and a normalized collision energy of 30% was used. Charge state 
screening was enabled, and charge states 2-6 were included. No threshold for 
signal intensities was applied, and precursor masses already selected for MS/MS 




MS data processing 
Raw files were processed with Progenesis QI for proteomics (Nonlinear 
Dynamics). In brief, runs were aligned to a reference sample containing the most 
comprehensive number of peptide ions to compensate for between run 
differences in the retention time.  Only peptide ions with a charge state of two, 
three and four were included into the analysis, default normalization was 
performed. For peptide identification, up to three tandem mass spectra per 
peptide ion were exported to a Mascot generic file (mgf) with fragment ion count 
limited to 200 and deisotoping as well as charge deconvolution was applied. 
Mascot (2.4.1) was used for searching a target-decoy mouse database 
downloaded from uniprot (03/01/2015), as decoys protein sequences were 
reversed and concatenated to the forward database. Parameters were set as 
following: peptide tolerance +-10ppm, MS/MS tolerance +-0.7DA, variable 
modifications: Acetyl (Protein N-term), Carbamidomethyl (C), Gln à pyro Glu (N-
term), N-Ethylmaleimide, N-Ethylmaleimide + water, oxidation (M). Resulting 
Mascot dat-files were imported into Scaffold 4 (Proteome Software) and the false 
discovery rate (FDR) for peptides was set to 0.01, for proteins to 0.05 
respectively. The Scaffold Spectrum Report was re-imported into Progenesis and 
relative quantitation using non-conflicting peptides was performed. Decoy hits 
were excluded and protein quantitation and statistics were exported as .csv files.  
Gene Ontology analysis  
Gene names, p-values and normalized protein abundance were exported to 
Metacore 6.24 build 67895 (Thomson Reuters). Members corresponding to the 
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GO terms: GO:0019395, GO:0006633, GO0006096, GO:0006098, GO:0008652, 
GO:0006099, GO: 0022904, GO:0006754 were exported. Changes in protein 
abundances were represented as histograms using Prism 6 (Graphpad).  
 
Radioactive FAO measurements 
Radioactively labeled palmitic acid ([9,10-3H(N)]palmitic acid (32Ci/mmol, 
NET043001MC) and [1-14C]palmitic acid (56.1mCi/mmol, NEC075H050UC) 
were purchased from Perkin Elmer. 
FAO of [9,10-3H(N)]palmitic acid was assessed by the production and 
release of tritiated water according to a modified procedure (Djouadi et al., 2003). 
Proliferating and quiescent NSPCs were grown in 24-well plates as described 
above and the tritiated water release experiments were performed in triplicate (3 
wells per sample/condition). A 500µM stock solution of [9,10-3H(N)]palmitic acid 
was prepared by complexing labeled and unlabeled palmitate to fatty acid-free 
albumin (PAA) as follows: 0.1mCi of 3H-palmitic acid and 130µl of 50mM 
palmitate (Sigma, dissolved in 100% ethanol) were mixed and dried under N2. 
13ml of BSA (2.5mg/ml) in PBS were added to the dried palmitate, vortexed 
vigorously and incubated in a shaker at 37 °C overnight. The palmitate/BSA 
stock solution was stored at -20 °C. The reaction was initiated by replacing the 
culture medium with 200µl of the reaction mixture. The reaction mixture was 
prepared by diluting the palmitate/BSA stock solution four-fold with cell culture 
medium and contained 0.385µCi [9,10-3H(N)]palmitic acid and 125µM sodium 
palmitate and 1mM L-carnitine (Sigma). The culture plate was wrapped in foil to 
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avoid evaporation and incubated for 4h at 37 °C. In some experiments, 100µM 
Etomoxir (Sigma), an inhibitor of mitochondrial FAO, was added to wells as a 
negative control. At the end of the incubation period, the reaction mixture from 
each well was transferred to a tube containing 200µl of cold 10% trichloroacetic 
acid (TCA) to stop the reaction. The tubes were centrifuged at 2200 g at 4 °C for 
10 min. The radioactive product 3H2O was eluted with 1.7ml deionized water and 
quantified by scintillation counting. Aliquots of supernatants (350µl) were 
removed and mixed with 55µl of 6M NaOH to neutralize the TCA. The total 
volume was applied to an ion-exchange column packed with 2.4ml of 0.37g/ml 
DOWEX 1X2 chloride form resin (200-400 mesh, Sigma). After the sample 
completely entered the column, the radioactive product 3H2O was eluted with 
1.7ml deionized water directly into a scintillation vial, mixed with 5ml of 
scintillation liquid (IRGASAFE Plus, Zinsser Analytic) and quantified by 
scintillation counting (Beckman Coulter LS 6500 Multi-Purpose Scintillation 
Counter). For the calculation of the specific radioactivity of the reaction mixture, 
20µl of the reaction mixture were mixed with 1.5ml H2O and 5 ml scintillation 
liquid. After removal of the reaction mixture cells were washed with PBS and 
lysed in 0.1M NaOH for protein determination using the BCA procedure (Pierce). 
The FAO of [1-14C]palmitic acid was assessed by the production and release of 
14CO2 according to a modified procedure of Huynh et al. (2014).  
A 2.5mM stock solution of [1-14C]palmitic acid was prepared by 
complexing labeled and unlabeled palmitate to fatty acid-free albumin as follows: 
the amount of radiolabeled palmitic acid in ethanol required to assay each 
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sample with 0.2µCi per well was dried under N2. The dried palmitate was 
resolubilized in the appropriate amount of 7% BSA/2.5mM palmitate warmed to 
37 °C to get a stock solution of 7% BSA/2.5mM palmitate/0.01µCi/ml 14C-
palmitate. The reaction mixture was prepared by diluting the palmitate/BSA stock 
solution 25-fold with cell culture medium and contained 0.2µCi [1-14C]palmitic 
acid and 100µM sodium palmitate and 1mM L-carnitine in 500µl medium. Cells 
were seeded in 24-well plates and the experiments were performed in 
quadruplicates (4 wells per sample/condition). The reaction was initiated by 
replacing the culture medium with 500µl of the reaction mixture. The culture plate 
was sealed with parafilm to avoid evaporation and incubated for 2.5h at 37 °C. In 
some experiments, 100µM Etomoxir was added to wells as a negative control. 
During the incubation, acidification vials with a 14CO2 trap were prepared by 
adding 200µl of 1M perchloric acid (Sigma) to tubes that contained a Whatman 
filter paper disc inside the cap that had been wetted with 20µl of 1M NaOH. At 
the end of the incubation, 400µl of the reaction mixture was added into an 
acidification vial to stop the reaction and incubated for 1h at room temperature. 
The paper disc was transferred to a scintillation vial, mixed with 5ml of 
scintillation liquid and quantified by scintillation counting. After removal of the 
reaction mixture cells were washed with PBS and lysed in 0.1M NaOH for protein 




Radioactive malonyl-CoA incorporation measurements 
Cells were incubated with 0.5 µCi [2-14C]malonyl-CoA (55 mCi/mmol; Cat. No. 
ARC 0528, American Radiolabeled Chemicals, USA) and 100 µM malonyl-CoA. 
After incubation, the cells were rinsed three times with PBS, and lipids were 
extracted with hexane:isopropanol (3:2). Manipulative losses of lipids were 
accounted for by addition of a known amount of [1,2-3H(N)]cholesterol (Cat. No. 
NET139250UC; PerkinElmer) as internal standard. After lipid extraction cells 
were lysed in 0.1 M NaOH for protein determination using the Pierce BCA 
Protein Assay Kit (Cat. No. 23227, Thermo Scientific, Rockford, IL, USA). 
Malonyl-CoA incorporation into specific lipids was analyzed after separation of 
lipids by thin-layer chromatography. Therefore, organic phases were evaporated 
to dryness under a nitrogen stream. Lipids were resuspended in chloroform and 
spotted together with appropriate lipid standards on silica gel 60 F254 plates (Cat. 
No. 1.05715.0001; Merck, Darmstadt, Germany). For separation of neutral lipids, 
plates were developed in heptane:diethylether:acetic acid (90:30:1) as solvent. 
Lipid samples and standards were visualized by iodine vapor. The lipid fractions 
were scraped from the plate, mixed with 5 ml of scintillation liquid (IRGASAFE 
Plus, Zinsser Analytic, Cat. No. 1003100) and quantified by scintillation counting 
(Beckman Coulter LS 6500 Multi-Purpose Scintillation Counter). Values were 





In utero electroporation and tissue preparation 
In-utero electroporation of mouse embryos (embryonic day 13, E13) from time-
mated C57BL/6JRj female mice was carried out as described previously (Asami 
et al., 2011). In brief the shRNA plasmid DNA (Cpt1a-shRNA1 or non-targeting 
shRNA; final concentration 0.5-0.7µg/µl) was targeted into the ventricular wall by 
repeated electrical pulses (ElectroSquireporator T830, Harvard Apparatus). After 
24h (corresponding to developmental stage E14), electroporated brains were 
dissected in ice cold PBS and fixed in phosphate buffered 4% paraformaldehyde 
(PFA; Sigma) on 4°C for 2 hrs. After rinse in PBS, embryonic brains were 
dehydrated in 30% sucrose (in PBS), embedded and frozen in OCT compound 
(Tissue-Tek; Sakura), and cut in slices of 30µm thickness using a Cryostat 
(Microm).  
 
Tissue preparation, Immunohistology and Immunocytochemistry  
Mice were transcardially perfused with 0.9% saline solution followed by 4% PFA 
solution. Brains were taken out and post-fixed overnight at 4°C in 4% PFA. After 
dehydration in 30% sucrose, 40µm thick free-floating sections were cut on a 
microtome (Leica). Sections were blocked for 1h with blocking buffer (0.25% 
Triton-x, 3% donkey serum in PBS) and subsequently incubated with primary 
antibodies in blocking buffer at 4°C overnight. Sections were washed 3x with 
PBS and incubated for several hours at room temperature with secondary 
antibodies in blocking buffer. Nuclei were stained with DAPI. After another 3 
washes with PBS sections were mounted (Shandon Immu-mount, Thermo 
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Scientific). For Spot14 stainings, section were pretreated for 5h at RT with a 
buffer containing 1%Triton-x and 3% donkey serum, followed by 3 days primary 
antibody incubation in blocking buffer. An additional enhancement step with a 
biotinylated secondary antibody followed by a streptavidin-coupled fluorophore 
was used. Cells were fixed with 4%PFA (37°C, fixed at RT for 20min), washed 3x 
with PBS and incubated in blocking buffer for 1h. Antibody stainings were done 
overnight at 4°C, secondary antibodies were incubated 2-4h at RT. 
The following primary antibodies and dilutions were used: mouse anti-pH3 
(1:1000, Abcam), mouse anti-Cpt1a (1:500, Abcam), rabbit anti-Ki67 (1:500m, 
Novocastra), chick-anti-GFP (1:500, Aves), goat anti-Sox2 (1:500, Santa Cruz), 
mouse anti-Nestin (1:500, BD Biosciences), goat anti-DCX (1:250, Santa Cruz), 
mouse-anti GFAP (1:500, Sigma), rabbit anti-Spot14 (1:250, Abcam), rabbit anti-
cleaved Caspase-3 (1:500, Cell signaling), rabbit anti-dsRed (1:500, Living 
Colors), mouse anti-Map2ab (1:500, Sigma), chick anti-GFAP (1:500, Aves). All 
secondary antibodies were raised in donkey and used 1:250 (Jackson 
ImmunoResearch). Mitotracker Deep red was added to cells for 1h at 37°C 
(100nM, Invitrogen), DAB staining was done according to the manufacturer’s 
protocol (Vectastain ABCKit, Vector Laboratories). EdU staining was performed 
before antibody incubation using the Click-iT EdU Imaging Kit (Invitrogen). 
 
Image acquisition and analysis  
Images of cell stainings were acquired using an Epifluorescent microscope 
(Zeiss Axiovert Observer). Images were analysed using ImageJ with customized 
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macros for automated detection in a blinded manner. For differentiated cells, 
confocal microscopy (LSM-700, Zeiss) was perfomed and z-projections were 
generated for analysis in ImageJ. Images were thresholded, a watershed filter 
was applied and DAPI positive nuclei were counted with the analyze particle 
function. To quantify MAP2ab positive cells masks of the MAP2ab channel were 
generated and DAPI positive nuclei inside the MAP2ab mask were counted using 
the particle analyzer. Image acquisition and analysis were performed in a blinded 
manner. For co-localization experiments, confocal microscopy (LSM-700, Zeiss, 
FV1000; Olympus) was performed. Images of brain tissue were acquired using a 
Zeiss AxioImager microscope (for DAB stainings) or by confocal microscopy 
(LSM-700, Zeiss). One-to-two series of sagittal sections (corresponding to a 6th-
3rd of the entire brain) were used from 2 months old Cpt1a-EGFP reporter mice 
(n=3-6) for quantification. To determine the percentage of Sox2 and DCX cells 
that were Cpt1a-eGFP+, analyses were carried out using both softwares Imaris 
(Bitplane) and ImageJ software.  In Imaris, a surface was first created using 
either the Sox2 or DCX channel.  Subsequently, this surface was used to mask 
the GFP signal.  A snapshot of the maximum projection of each raw channel as 
well as each masked channel was saved for further import into ImageJ.  To 
demarcate the SGZ, DAPI and DCX images were merged to outline the specified 
region.  Bright Sox2 or DCX positive cells within the SGZ were circled to create 
region of interests (ROIs).  These ROIs were then overlaid onto the masked GFP 
channel to determine if the Sox2+ or DCX+ cells were Cpt1a-eGFP+.  At least 3 
sections from 3 different animals were used to count >50 cells for each condition. 
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The same procedure was used to determine the number of Nestin-positive 
processes that also were Cpt1a-eGFP+. 
For the in utero electroporation experiments, images were analyzed in a 
blinded manner with ImageJ. A region of interest was drawn over the mCherry 
positive area (stained as described above) from the ventricular zone to the pial 
surface. This region of interest was then applied to the adjacent sections stained 
against cleaved Caspase 3. A threshold was set and the %area covered by 
Caspase-3 positive cells was measured. 4-5 sections per embryo were analyzed 
(non-targeting n=4 embryos, Cpt1a shRNA1 n=5 embryos). For pH3 
quantification, regions with mCherry signal were selected and signal intensity of 
corresponding adjacent sections stained for pH3 were analyzed with ImageJ. 
Mean gray values 40µm from the apical surface into the ventricular zone were 
measured along the electroporated area and plotted in relation to distance. 3-4 




Serial 40µm sections of an entire hemisphere per mouse were stained with 
antibodies against GFP, Sox2 and doublecortin (DCX). All sections containing 
GFP positive cells were imaged with a 20x confocal microscope (for cellular 
identification) as well as with a 5x Epifluorescent microscope (for reconstruction). 
Cell identity was determined in a blinded manner based on the following criteria, 
similar to what has been previously described (Bonaguidi et al., 2011). 
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Radial-glia like cell (R): triangular shaped soma in SGZ with radial, arborized 
process into GCL (sometimes not entirely visible), Sox2 positive, DCX negative. 
Neural progeny (N): this group contains non-radial cells (more oval to roundish 
soma in SGZ with one or more horizontal process, Sox2 positive), progenitor 
cells (roundish soma in SGZ, DCX positive but without long vertical process yet, 
sometimes still Sox2 positive) and immature/mature neurons (round soma in 
GCL with long more or less vertical process, Sox2 negative, usually DCX positive, 
but sometimes DCX already absent). Astrocytes (A): multi-process containing, 
star shaped or bushy cell in SGZ/Hilus or GCL. 
After cellular identification, clonal reconstruction was done based on the order of 
sections and based on the 5x overview images, followed by image overlay with 
the software Free-D (http://free-d.versailles.inra.fr/) and Photoshop (Adobe). 
Cells within the same spatial location and not more than 160µm apart in all 3 
dimensions were assigned as belonging to a single clone. In the 25d timepoint 
group, a total of 62 clones were identified from three S14iCre-R26YFP-
Cpt1acKO wt/wt mice (two females, one male) and a total of 34 clones were 
identified from seven S14iCre-R26YFP-Cpt1acKO fl/fl mice (six females, one 
male). In the 8d timepoint, a total of a total of 24 clones were identified from four 
S14iCre-R26YFP-Cpt1acKO wt/wt mice (three females, one male) and a total of 
17 clones were identified from five S14iCre-R26YFP-Cpt1acKO fl/fl mice (four 
females, one male). 




RNA of proliferating, quiescent, re-plated proliferating and formerly quiescent 
NSPCs (grown as described above) as well as of NSPCs treated with the PPARα 
agonist Wy14643, control NSCPs and quiescent NSPCs grown in parallel was 
isolated with the Nucleo Spin RNAII Kit (Macherey & Nagel). cDNA was 
synthesized using the Superscript III Kit (Invitrogen) according to the 
manufacturer’s protocol. Taqman probes against mouse Cpt1a, Spot14 and β-
actin and RT-PCR master mix were obtained from Applied Biosystems and used 
according to the manufacturer’s protocol. Real time PCR and data analysis was 
performed on an Applied Biosystems 7900HT System. Fold changes were 
calculated using the deltadelta Ct methods. 
For PPARα target gene analysis, qRT-PCR was performed on a Roche 
LightCycler 480 in LightCycler 480 Multiwell Plate 96. The 20 µl amplification 
mixture consisted of 2x KAPA SYBR FAST qPCR Mastermix (KAPA 
Biosystems,) and 4 pmol forward and reverse primers (Microsynth, Switzerland) 
and approximately 10 ng of cDNA template. Thermal cycling was carried out with 
a 5 min denaturation step at 95 °C, followed by 45 three-step cycles: 10 sec at 
95 °C, 10 sec at 60 °C, and 10 sec at 72 °C. Finally, melt curve analysis was 
carried out to confirm the specific amplification of a target gene and absence of 
primer dimers. All reactions were run in duplicate. Relative mRNA amount was 
calculated using the deltadelta Ct methods. Cyclophilin was used as the invariant 
control. Results were confirmed with 18S rRNA as the invariant control (data not 
shown). Primers used are listed in Table S3.  
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Western Blot  
Proliferating and quiescent NSPCs were lysed in RIPA buffer containing protease 
inhibitors (Complete, Roche). Protein amount was determined with a BC assay 
(Uptima) and equal amounts of proteins were separated by SDS-PAGE 
electrophoresis followed by transfer to PVDF membrane (BioRad). Membranes 
were incubated with mouse anti-Cpta1 (1:2000, Abcam) and mouse anti-beta-
actin (1:10’000, Sigma). HRP-conjugated secondary antibodies (Jackson 
immunoResearch) were used and signal was revealed by enhanced 
chemiluminescence substrate (ThermoScientific). 
 
Malonyl-CoA and acetyl-CoA measurements 
Proliferating and quiescent NSPCs were washed with 75mM ammonium 
carbonate pH 7.4 and plates were snap frozen with liquid nitrogen. Metabolites 
were extracted with cold acetonitrile:methanol:water solvent (40:40:20) at -20°C 
for 10 minutes and an extraction step was repeated once. Samples were 
centrifuged at 13000rpm for 3 minutes and kept at -80°C. Extracts were dried by 
vacuum-centrifugation, re-suspended in 50µl water and analyzed by LC-MS/MS 
on a Thermo Quantum Ultra instrument equipped with a Waters Acquity UPLC 
(Buescher et al., 2010). Data analysis was performed using our own software 
written in Matlab (The Mathworks). Cell numbers of proliferating and quiescent 
NSPCs were assessed in separate plates grown in parallel using live Hoechst 
(5µg/ml, Invitrogen). 12 low magnification images from each triplicate were taken 
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and the number of nuclei counted using ImageJ. Measured malonyl-and acetyl-
CoA values were normalized to the average cell number. 
 
C13-incorporation and energy charge measurements 
Proliferating and quiescent NSPCs were incubated for 24h with the 
corresponding medium containing 100µM C13-labelled palmitate (Cambridge 
Isotope Laboratories Inc.). Palmitate was coupled to BSA to achieve better 
cellular uptake. Metabolites were extracted with 800µL 80% methanol (at -80 °C), 
cells were scraped and the extracts were transferred to a 1.5ml tube. Next the 
extracts were centrifuged at 4°C for 15min at 20,000xg. The supernatant was 
dried using a vacuum centrifuge. To the dried fractions 25µL of a 2% 
methoxyamine hydrochloride solution (20mg dissolved in 1mL pyridine) was 
added and placed at 37°C for 90min. Then 75µl of N-tert-Butyldimethylsilyl-N-
methyltrifluoro-acetamide with 1% N-tert-Butyldimethyl- chlorosilane (Sigma-
Aldrich, Belgium) was added and the reaction was carried out for 30min at 60°C. 
Reaction mixtures were centrifuged for 15min at 20,000xg at 4°C in order to 
remove insolubilities, and the supernatant was transferred to a glass vial with 
conical insert (Agilent). GC-MS analyses were performed using an Agilent 7890A 
GC equipped with a HP-5 ms 5% Phenyl Methyl Silox (30 m - 0.25 mm i.d. - 0.25 
µm; Agilent Technologies, Santa Clara, California, USA) capillary column, 
interfaced with a triple quadruple tandem mass spectrometer (Agilent 7000B, 
Agilent Technologies) operating under ionization by electron impact at 70eV. The 
injection port, interface and ion source temperatures were kept at 230°C. 
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Temperature of the quadrupoles was maintained at 150°C. The injection volume 
was 1µl, and samples were injected at 1:10 split ratio. Helium flow was kept 
constant at 1 ml/min. The temperature of the column started at 100 °C for 5 min 
and increased to 260 °C at 2°C/min. Next, a 40°C/min gradient was carried out 
until temp reached 300°C. After the gradient, the column was heated for another 
3 min at 325°C. The GC-MS analyses were performed in Single Ion Monitoring 
(SIM) scanning for the isotopic pattern of metabolites. 
For energy charge measurements (which is defined as following: 
(ATP+0.5*ADP)/(ATP+ADP+AMP)), metabolites of proliferating and quiescent 
NSPCs were extracted using 250 uL of an 80% methanol solution. Measurement 
of ATP, ADP and AMP levels was performed using a Dionex UltiMate 3000 LC 
System (Thermo Scientific) coupled to a Q Exactive Orbitrap mass spectrometer 
(Thermo Scientific) operated in negative mode. Practically, 30 µl of sample was 
injected on a SeQuant ZIC/ pHILIC Polymeric column (Merck Millipore). The 
gradient started with 20% of solvent B (2 mM Na-acetate in mqH2O, pH 9.3) and 
80% solvent A (95:5, acetonitrile:mqH2O, containing 2 mM Na-acetate at pH 9.3) 
and remained at 20% B until 2 min post injection. Next, a linear gradient to 80% 
B was carried out until 29 min. At 38 min the gradient returned to 40% B followed 
by a decrease to 20% B at 42 min. The chromatography was stopped at 58 min. 
The flow was kept constant at 100 uL/min at the column was placed at 25°C 
throughout the analysis. 
The MS operated both in full scan mode using a spray voltage of 3.2 kV, capillary 
temperature of 320°C, sheath gas at 10.0, auxiliary gas at 5.0. AGC target was 
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set at 1e6 using a resolution of 70.000, with a maximum IT of 100 ms.  Data 
collection was performed using Xcalibur software (Thermo Scientific).  
 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Quantifications were done as described in the METHOD DETAIL section. 
 
Statistical analyses were performed with the software Prism 6 (GraphPad). 
Significance levels were set at *p < 0.05, **p < 0.01 and ***p < 0.001. 
The following tests were used:  
Figure 1: A: unpaired t-test, two-tailed, n=3 coverslips per condition (10 images 
per coverlip), B: Wilcoxon matched-pairs signed Rank test against the 
hypothetical value 0. C: One-way-ANOVA followed by Holm-Sidak's multiple 
comparisons test, n=3 samples per condition. D and F: One-way-ANOVA 
followed by Holm-Sidak's multiple comparisons test, n=3 samples per condition. 
E: unpaired t-test, two-tailed, n=3 samples per condition. G: unpaired t-test, two-
tailed, n=3 samples per condition 
Figure 2: A: 2-way ANOVA with multiple comparisons, n=3 wells per condition 
(4-6 adjacent areas per well). B: unpaired t-test, two-tailed, n=3 samples per 
condition. C: One-way-ANOVA followed by Holm-Sidak's multiple comparisons 
test, n=3 samples per condition. D: unpaired t-test, two-tailed, n=3 samples per 
condition. F: One-way-ANOVA followed by Holm-Sidak's multiple comparisons 
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test, n=3 samples per condition. G: One-way-ANOVA followed by Holm-Sidak's 
multiple comparisons test, n=3 samples per condition. 
Figure 3: B, C and D: paired t-test, two-tailed, n=3 mice (50-100 cells per 
mouse). 
Figure 4: B, C and D: Contingency analysis, Chi2-test, n=62 clones for S14iCre 
+/-; Cpt1a cKO wt/wt; R26YFP fl/wt, n=34 clones for S14iCre +/-; Cpt1a cKO fl/fl; 
R26YFP fl/wt. 
Figure 5: A and B: One-way-ANOVA followed by Holm-Sidak's multiple 
comparisons test, n=3 coverslips per condition (10 images per coverlip). 
Supplemental Figure 1: B: unpaired t-test, two-tailed, n=3 samples per 
condition. C: unpaired t-test, two-tailed, n=3 samples per condition. F: Wilcoxon 
matched-pairs signed Rank test against the hypothetical value 0. G: unpaired t-
test, two-tailed, n=3 samples per condition.  
Supplemental Figure 2: A: 2-way ANOVA with multiple comparisons, n=3 wells 
per condition (4-6 adjacent areas per well). B: One-way-ANOVA followed by 
Holm-Sidak's multiple comparisons test, n=3 samples per condition. C: One-way-
ANOVA followed by Holm-Sidak's multiple comparisons test, n=3 coverslips per 
condition (10 images per coverslip). D: One-way-ANOVA followed by Holm-
Sidak's multiple comparisons test, n=3 samples per condition. 
Supplemental Figure 4: A, B and C: Contingency analysis, Chi2-test, n=24 
clones for S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt, n=17 clones for S14iCre 
+/- ; Cpt1a cKO fl/fl; R26YFP fl/wt. D: grouped analysis, multiple t-tests, two 
tailed, n= 4 mice for S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt, n=5 mice for 
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S14iCre +/- ; Cpt1a cKO fl/fl; R26YFP fl/wt. E: grouped analysis, multiple t-tests, 
two tailed, n= 3 mice for S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt, n=7 mice 
for S14iCre +/- ; Cpt1a cKO fl/fl; R26YFP fl/wt. F: unpaired t-test, two tailed, n= 4 
mice for S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt, n=5 mice for S14iCre +/- ; 
Cpt1a cKO fl/fl; R26YFP fl/wt. G: unpaired t-test, two tailed, n= 3 mice for 
S14iCre +/-; Cpt1a cKO wt/wt; R26YFP fl/wt, n=7 mice for S14iCre +/- ; Cpt1a 
cKO fl/fl; R26YFP fl/wt. I: unpaired t-test, two tailed, n= 3 samples per condition. 
L: 2-way ANOVA followed by uncorrected Fisher’s LSD, n=3 embryos (4-5 slices 
per animal) non-targeting shRNA, n=4 embryos (4-5 slices per animal) Cpt1a 
shRNA. M: unpaired t-test, two tailed, n=4 embryos (4-5 slices per animal) non-
targeting shRNA, n=5 embryos (4-5 slices per animal) Cpt1a shRNA. 
Supplemental Figure 5: B: Unpaired t-test, two tailed, n= 3 samples per 
condition, D: One-way-ANOVA followed by Holm-Sidak's multiple comparisons 
test, n=3 coverslips per condition (10 images per coverlip). 
 
DATA AND SOFTWARE AVAILABILITY 
The mass spectrometry proteomics data have been deposited to the 
ProteomeXchange Consortium via the PRIDE partner repository with the dataset 
identifier PXD005598 
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